These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5356668)

  • 1. [Clinical effect of dipyridamole indicated by the prognosis of myocardial infarction].
    Itatsu H
    Iryo; 1969 Aug; 23(8):1059-67. PubMed ID: 5356668
    [No Abstract]   [Full Text] [Related]  

  • 2. On the factors which affect the immediate and long-term prognosis of myocardial infarction.
    Itatsu H
    Jpn Circ J; 1967 Nov; 31(11):1600-2. PubMed ID: 5630881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dipyridamole therapy in acute myocardial infarct].
    Avdiushko BR
    Vrach Delo; 1977 Jan; (1):38-43. PubMed ID: 841989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognostic value of dipyridamole echocardiography in 1st acute uncomplicated myocardial infarction].
    Sánchez P; Paré JC; Azqueta M; Sanz GA
    Med Clin (Barc); 1998 Feb; 110(7):241-6. PubMed ID: 9562947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term prognosis for patients undergoing thrombolysis during the acute phase of myocardial infarction].
    Bosset AJ; Vogt P; Eeckhout E; van Melle G; Monnier P; Schaller MD; Stauffer JC; Kappenberger L; Goy JJ
    Ann Cardiol Angeiol (Paris); 1997; 46(5-6):303-10. PubMed ID: 9295890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
    Teik KO; Poh FW; Fun CS; Mong BC
    Med J Malaya; 1966 Mar; 20(3):186-204. PubMed ID: 4223070
    [No Abstract]   [Full Text] [Related]  

  • 10. Uncomplicated non-Q wave myocardial infarction: long-term prognosis with a conservative echo-stress guided management strategy.
    Cecchi E; Brusasco G; Tidu M; Imazio M; Chinaglia A; Pomari F; Moratti M; Ghisio A; Trinchero R
    Ital Heart J; 2002 May; 3(5):322-9. PubMed ID: 12066565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observations on the treatment of myocardial infarct with dipyridamole and polarizing solutions in intravenous administration].
    Martinetti L; Furlotti-Marino G
    Minerva Med; 1968 Aug; 59(69):3522-45. PubMed ID: 5676220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of dipyridamol in the acute period of myocardial infarction].
    Avdiushko BR
    Vrach Delo; 1977 Jan; (1):38-43. PubMed ID: 847943
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ramipril after myocardial infarct. Long lasting cardiovascular protective action].
    MMW Fortschr Med; 2003 Sep; 145(39):46. PubMed ID: 14649074
    [No Abstract]   [Full Text] [Related]  

  • 14. Doubts about dipyridamole as an antithrombotic drug.
    Drug Ther Bull; 1984 Apr; 22(7):25-8. PubMed ID: 6368165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute myocardial infarct using dipyridamole in continuous venoclysis].
    Nolla Panadés J
    Rev Clin Esp; 1970 Jun; 118(1):73-80. PubMed ID: 5457397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L; Balzano I
    Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term prognosis of patients resuscitated during myocardial infarction. Follow-up study 57 years after resuscitation].
    Rutlin E; Dybdahl JH; Berg-Larsen R
    Tidsskr Nor Laegeforen; 1983 Feb; 103(6):588-91. PubMed ID: 6868032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of myocardial viability very early after acute myocardial infarction by ultra-low dose echo-dipyridamole test].
    Silvestri O; Polimeno S; Gaeta G; Boccalatte A
    G Ital Cardiol; 1996 Nov; 26(11):1257-66. PubMed ID: 9036022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.